Crop-chemical maker FMC just cratered on weak farm demand and a pricing shakeup — short the dead-cat bounce

Verdict: the bear case is intact, but the easy part of FMC's decline is already priced

The strongest point for this short is that the demand downgrade is real and still ongoing: Q2 2026 revenue of $867.1M is down roughly 17.5% year over year, the company is still losing money (-$186.6M net income, a -21.5% net margin), and leverage keeps climbing — debt-to-equity rose from 2.49 in Q1 to 2.62 in Q2 after reaching 0.75 at end-2024. The strongest point against it is that the most recent quarter was a broad-based inflection, not continued collapse: free cash flow swung from -$617.5M to +$357.7M, gross margin recovered about 7 points to 39.5%, and the cash buffer ($584.5M of cash, a 1.32 current ratio, and a full-year free cash flow ranking in the 90th percentile of Materials peers) undercuts the funding-squeeze leg of the thesis at the company level. The dividend cut to $0.08 per quarter — an 86% annual reduction — is already in the price, as is the drop to $5.66, down 81.5% from the 52-week high, with RSI at 8.9 marking an oversold tape where a bounce is plausible. The setup is a watch-list framework, not an active signal: no trade opened in the last 12 months on 248 evaluated bars, and no robust parameter setup was established because daily data coverage remained incomplete. The verdict is wait — let the rules execute on their own terms, and treat a close back above the declining 50-day moving average near $10.19 (about 80% above the last close) as the thesis-killer.

Trade now

**FMC is a watch-list short, and the market has already done most of the moving.** The stock closed at $5.66 on October 16, down 81.5% from its 52-week range high, sitting just 0.7% above the range low. The 50-day moving average is at $10.19 and the 200-day at $12.94 — price is roughly $4.53 below even the faster of the two. Momentum confirms the breakdown: RSI (14) at 8.9, MACD histogram at -1.03, and ADX at 37.5, well above the 20 threshold that marks a trending market. All six entry conditions for the Confirmed Breakdown Short are evaluated as met at these levels — price below the 50-day, MACD below zero, RSI below 50, ADX above 20, and price below the 10-day Donchian channel at $7.08. The setup is defined by its entry conditions, and this is a waiting framework rather than an open position: the strategy did not open a trade over the last 12 months on 248 evaluated bars. **Know your exits before anything triggers.** The invalidation is explicit: a close at or above the declining 50-day moving average, currently $10.19 — about 80% above the last close. The fixed risk guard is a 2.9% stop on position P&L against a 5.7% take-profit, roughly a 2:1 reward-to-risk on the managed position, with a hard 90-day time exit if neither is hit. Position sizing is fixed-risk at 2.85% of equity per trade, capped at 25% of the portfolio. In plain terms: wait means no action until the entry framework opens a position on its own terms, and if the stock reclaims $10.19 the bearish thesis is wrong regardless of how cheap the shares look. **The fundamentals support the bearish framing without needing to chase.** Q2 2026 (period ended June 30) showed revenue of $867.1M, up 14.3% quarter over quarter but still deeply unprofitable: net income of -$186.6M, a net margin of -21.5%, and operating margin deteriorating 3.13 points to -13.8%. Debt-to-equity rose to 2.62 from 2.49. Free cash flow turned positive at $357.7M after a -$617.5M quarter, which is the one genuinely constructive data point — but a $0.08 per-share quarterly dividend (annualized $0.32, down from $2.32 trailing a year ago) signals the company itself has reset its capital-return expectations. One honest caveat: no robust parameter setup was established because market-data coverage for FMC's daily bars remains incomplete, so the frozen settings are what you get — no optimized variant was searched. **Bottom line:** conditions are aligned with the thesis today, the stop is unambiguous, and the risk budget is small and mechanical. The right move is to have the order framework armed and let the rules execute — not to anticipate them.

The Fundamental Downgrade Is Real: Demand, Pricing, and Now Credit All Point Down

The idea argues FMC's collapse reflects a structural downgrade of the crop-chemical story, and the fundamentals back that up. Full-year 2025 was brutal: revenue fell to $3.47B, the company posted a net loss of $2.24B, and the third quarter of 2025 alone saw a $569.3M net…

Scores

• Conviction score breakdown: 52
• Thesis support: 68
• Trade readiness: 45
• Risk quality: 55
• Trigger proximity: 40
• Fundamentals trend: 52

Watch items

• FMC — Price vs Donchian (10)
• FMC — Price vs 50-day SMA
• FMC — RSI (14)
• FMC — ADX (14)
• FMC — Free cash flow (next quarterly report)
• FMC — Debt-to-equity ratio
• FMC — Gross margin
• FMC — Institutional ownership filing (period ended 2026-09-30)
• FMC — Quarterly dividend per share